BKV (NYSE:BKV - Get Free Report) had its price target hoisted by equities researchers at KeyCorp from $25.00 to $27.00 in a research report issued on Monday,Benzinga reports. The firm currently has an "overweight" rating on the stock. KeyCorp's target price would indicate a potential upside of 13.40% from the company's previous close.
BKV has been the topic of a number of other research reports. Barclays initiated coverage on BKV in a research note on Monday, October 21st. They set an "overweight" rating and a $24.00 price target on the stock. Evercore ISI started coverage on shares of BKV in a research note on Monday, October 21st. They set an "outperform" rating and a $24.00 price objective on the stock. Susquehanna increased their target price on BKV from $24.00 to $25.00 and gave the company a "positive" rating in a research report on Wednesday, November 13th. Jefferies Financial Group began coverage on shares of BKV in a research note on Monday, October 21st. They issued a "buy" rating and a $28.00 target price on the stock. Finally, Truist Financial raised their target price on BKV from $24.00 to $25.00 and gave the stock a "buy" rating in a research note on Tuesday, November 19th. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $27.50.
View Our Latest Research Report on BKV
BKV Trading Down 2.6 %
NYSE BKV traded down $0.64 during midday trading on Monday, hitting $23.81. 635,709 shares of the company traded hands, compared to its average volume of 422,857. The firm has a 50-day simple moving average of $21.91. BKV has a 52 week low of $17.39 and a 52 week high of $24.93.
BKV Company Profile
(
Get Free Report)
BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.
Read More
Before you consider BKV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.
While BKV currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.